|
SPCS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.434800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.889000E-01 |
| Normal-vs-Stage2 |
7.149800E-01 |
| Normal-vs-Stage3 |
9.398400E-01 |
| Normal-vs-Stage4 |
2.452000E-01 |
| Stage1-vs-Stage2 |
4.043000E-01 |
| Stage1-vs-Stage3 |
6.252400E-01 |
| Stage1-vs-Stage4 |
1.328840E-01 |
| Stage2-vs-Stage3 |
8.300200E-01 |
| Stage2-vs-Stage4 |
3.750000E-01 |
| Stage3-vs-Stage4 |
4.319800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.313000E-01 |
| Normal-vs-AfricanAmerican |
9.102800E-01 |
| Normal-vs-Asian |
1.881640E-01 |
| Caucasian-vs-AfricanAmerican |
7.791600E-01 |
| Caucasian-vs-Asian |
1.488020E-01 |
| AfricanAmerican-vs-Asian |
2.058800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.744800E-01 |
| Normal-vs-Female |
1.815390E-01 |
| Male-vs-Female |
8.618100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.325400E-01 |
| Normal-vs-Extreme_Weight |
5.843600E-01 |
| Normal-vs-Obese |
5.940600E-01 |
| Normal-vs-Extreme_Obese |
7.948600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.512200E-02 |
| Normal_Weight-vs-Obese |
1.000760E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.806400E-01 |
| Extreme_Weight-vs-Obese |
9.217600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.580200E-01 |
| Obese-vs-Extreme_Obese |
9.291600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.363230E-01 |
| Normal-vs-Age(41-60Yrs) |
8.941800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.845800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.601800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.109650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.830300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.173700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.207400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.192600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.752000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.243000E-01 |
| Normal-VS-Type2 PRCC |
2.547800E-01 |
| Normal-VS-KIRP CIMP |
1.039020E-01 |
| Normal-VS-Unclassified PRCC |
6.535000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.739560E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.811900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.621200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.888200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.465400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.503800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.720000E-01 |
| Normal-vs-N1 |
6.240400E-01 |
| Normal-vs-N2 |
8.343400E-01 |
| N0-vs-N1 |
5.373400E-01 |
| N0-vs-N2 |
7.766400E-01 |
| N1-vs-N2 |
9.412600E-01 |
|
|
